Oceania Healthcare (OCA) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
1 Jul, 2025Refinance and capital structure
Debt facilities refinanced at $500m with extended tenor, optimal pricing, and no covenant changes; new syndicate member added and no need for additional capital or borrowings.
Banking syndicate support reaffirmed, with improved debt maturity profile and $1m annual fee savings; gearing at 37.5% with $96m headroom as of September 2024.
Targeting gearing below 35% through unsold stock sales and a reduced-intensity development pipeline.
Sales and operational performance
New sales volumes up 29% and resales up 6% in 3Q25 vs 3Q24; unsold stock of $361m is key for debt reduction.
Sell-down progress at The Helier (Auckland) with 34% occupancy expected by March 2025; new sales leadership appointed.
Applications in Jan-Feb 2025 up 28% year-on-year; care suite model acceptance remains strong.
Development pipeline and portfolio strategy
Meadowbank dementia building (40 suites) and Franklin (31 villas) under construction, on track for May 2025 and Jan 2026 completion.
Awatere and Waterford developments completed, with 8 residents and 5 applications representing 11% of new stock.
Brownfield landbank focused on lower-density developments; recent land acquisition at Gracelands, Hawkes Bay.
Latest events from Oceania Healthcare
- Asset and sales growth, no FY25 dividend, and focus on efficiency and sustainability.OCA
AGM 20253 Feb 2026 - Strong financial growth, reinvestment, and innovation shape future strategy.OCA
AGM 20243 Feb 2026 - EBITDA up 2.7%, gearing down, but net profit fell; sales and debt reduction prioritized.OCA
H1 202512 Jan 2026 - EBITDA up 23%, care profitability surged, and gearing improved to 34.8% amid strong sales.OCA
H1 202621 Nov 2025 - Underlying EBITDA up 4.1%, sales volumes up 9.2%, and gearing reduced.OCA
H2 202518 Nov 2025 - Disciplined execution and service innovation drive sustainable growth and returns to FY31.OCA
Investor Day 2025 Presentation15 Sep 2025 - Underlying EBITDA rose 4.1% as sales volumes and operational efficiency both improved.OCA
Investor Presentation1 Jul 2025